ABVC BioPharma Inc. (ABVC) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ABVC BioPharma Inc.

    NASDAQ: ABVC · Real-Time Price · USD
    3.03
    0.01 (0.33%)
    At close: Oct 03, 2025, 3:59 PM
    3.00
    -0.99%
    After-hours: Oct 03, 2025, 07:53 PM EDT

    ABVC BioPharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 248.38K 60.16K 85.27K 5.83M
    Short-Term Investments
    		 64.74K 79.31K 75.8K 108.15K
    Long-Term Investments
    		 2.26M 2.53M 842.07K 932.75K
    Other Long-Term Assets
    		 1.95M 1.53M 4.17M 160.47K
    Receivables
    		 1.16M 759.57K 1.37M 1.71M
    Inventory
    		 n/a n/a 1.31M 25.98K
    Other Current Assets
    		 711.65K 757.68K n/a 736.67K
    Total Current Assets
    		 2.18M 1.66M 2.99M 9.63M
    Property-Plant & Equipment
    		 1.15M 8.78M 1.74M 2M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 5.36M 12.84M 6.87M 4.07M
    Total Assets
    		 7.54M 14.49M 9.86M 13.7M
    Account Payables
    		 n/a n/a n/a n/a
    Deferred Revenue
    		 81.11K 79.5K 10.98K 10.98K
    Short-Term Debt
    		 2.55M 1.47M 1.89M 1.64M
    Other Current Liabilities
    		 -462.25K 2.51M 468.15K n/a
    Total Current Liabilities
    		 6.56M 5.93M 5.54M 3.69M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 21.68K 21.68K 7.98K 10.58K
    Total Long-Term Liabilities
    		 258.49K 429.14K 799.81K 1.14M
    Total Liabilities
    		 6.82M 6.36M 6.34M 4.83M
    Total Debt
    		 3.2M 2.28M 3.05M 3.11M
    Book Value
    		 723.96K 8.13M 3.51M 8.87M
    Book Value Per Share
    		 0.06 1.88 1.11 3.54
    Common Stock
    		 13.87K 7.94K 3.29K 28.93K
    Retained Earnings
    		 -68.95M -65.42M -54.9M -38.48M
    Comprehensive Income
    		 445.67K 516.39K 517.13K 539.66K
    Shareholders Equity
    		 1.23M 8.39M 3.1M 8.84M
    Total Investments
    		 2.32M 2.61M 917.87K 1.04M

    Add to Watchlist